Patent details

EP3302516 Title: BIOLOGICALLY CLEAVABLE TETRAPEPTIDE LINKING AGENTS

Basic Information

Publication number:
EP3302516
PCT Application Number:
US2016034517
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168040905
PCT Publication Number:
WO2016196243
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BIOLOGICALLY CLEAVABLE TETRAPEPTIDE LINKING AGENTS
French Title of Invention:
AGENTS DE LIAISON TÉTRAPEPTIDIQUES BIOLOGIQUEMENT CLIVABLES
German Title of Invention:
BIOLOGISCH SPALTBARE TETRAPEPTID-LINKER
SPC Number:

Dates

Filing date:
27/05/2016
Grant date:
30/12/2020
EP Publication Date:
11/04/2018
PCT Publication Date:
08/12/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/12/2020
EP B1 Publication Date:
30/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/05/2021
Expiration date:
27/05/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/12/2020
 
 

Name:
Arrowhead Pharmaceuticals, Inc.
Address:
177 E. Colorado Boulevard, Suite 700, Pasadena, CA 91105, United States (US)

Inventor

1

Name:
BLOKHIN, Andrei, V.
Address:
United States (US)

2

Name:
CARLSON, Jeffrey, C.
Address:
United States (US)

Priority

1

Priority Number:
201562168244 P
Priority Date:
29/05/2015
Priority Country:
United States (US)

2

Priority Number:
201562235833 P
Priority Date:
01/10/2015
Priority Country:
United States (US)

Classification

IPC classification:
C07K 5/103; C07K 5/107; A61K 47/54; A61K 47/60; A61K 47/64; A61K 47/65;

Publication

European Patent Bulletin

Issue number:
202053
Publication date:
30/12/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages